Stock prices of twelve of the largest pharmaceutical companies in the USA have fallen sharply after the commencement of a Congressional investigation into prescription drug pricing practices. In a statement released yesterday, it was revealed that the House Oversight Committee chaired by Senator Elijah Cummings (D-Md) sent letters requesting information about their pricing strategies to AbbVie, Amgen, AstraZeneca, Celgene, Eli Lilly, Johnson & Johnson, Mallinckrodt, Novartis, Novo Nordisk, Pfizer, Sanofi, and Teva Pharmaceuticals as part of an inquiry into alleged price profiteering.

Political Hot Button

According to information from the committee, the information requests included inquiries about three drugs respectively from AbbVie and Sanofi, two drugs respectively from Amgen, Pfizer and Novo Nordisk, and one drug each from AstraZeneca, Celegne, Eli Lilly, Johnson & Johnson, Novartis, Mallinckrodt and Teva.

Both Democrats and Republicans agree that something needs to be done to reduce prescription prices which are higher in the USA than pretty much anywhere else in the world.

President Donald Trump’s administration has introduced a number of reform proposals to lower price burdens for consumers – $333.4 billion in 2017 – including changes to Medicare Part B and Part D. House Democrats on their part have also made efforts to achieve price reductions including most recently a trio of bills sponsored last week by Senator Cummings, Senator Bernie Sanders (D-Vt) and Rep. Ro Khanna (D-Ca).

An excerpt from the committee’s statement reads as follows:

For years, drug companies have been aggressively increasing prices on existing drugs and setting higher launch prices for new drugs while recording windfall profits. The goals of this investigation are to determine why drug companies are increasing prices so dramatically, how drug companies are using the proceeds, and what steps can be taken to reduce prescription drug prices.

Pharma Stock Prices Fall Following Announcement

In the wake of the news of the information requests sent to the 12 companies, their stock prices recorded sharp declines, led by AstraZeneca which fell 7.69 percent from $37 to $35.22 in a few hours of trading yesterday.

AstaZeneca stock dipped 7.69% on the news. Chart from Tradingview.

Pfizer stocks also dipped 2.78 percent on the news, falling from $42.80 to $42.36.

Pfizer stocks also dipped 2.78%. Chart from Tradingview.

Of the rest, Johnson & Johnson was the smallest loser, recording a price dip of 0.29 percent from $129.50 to $128.31.


Johnson & Johnson stock only dropped 0.29%. Chart from Tradingview.
You May Also Like

Elon Musk’s Inspiration for the Lame Cybertruck Was a James Bond Movie

The Tesla Cybertruck may have been inspired by some cool vehicles, but that doesn’t mean truck-owners will get on board with the design.

New Trump Tariffs Could Send Beer Prices Soaring

Another round of surprise Trump tariffs are the president’s remedy for weaker foreign currencies, but it could be bitter news for beer prices.

5 Reasons McDonald’s Chicken Sandwich Won’t Be a Chick-fil-A Killer

McDonald’s joins the chicken sandwich wars with the Crispy Chicken Sandwich, but it will be no match for Chick-fil-A’s product or brand.

Billionaire Ray Dalio: US Empire Fading as Shanghai Becomes World Financial Hub

Ray Dalio believes that the U.S. empire is losing steam. China is on the rise, and if the trade war goes awry, it will lead to chaos.

Hey Larry Page & Sergey Brin, You Forgot to Sign the Giving Pledge on Your Way Out

Larry Page and Sergey Brin’s fans will be disappointed as they leave Google. So will Bill Gates and Warren Buffett, but for different reasons.

YouTube Rewind 2019 Is the Blandest Thing on the Face of the Planet

YouTube Rewind 2019 is here, and it is the blandest video that has ever existed.